Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Cyclophosphamide/tacrolimus

Thrombotic microangiopathy: 4 case reports

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Miyata R, Shimazu M, Tanabe M, Kawachi S, Hoshino K, Wakabayashi G, Kawai Y, Kitajima M.Clinical characteristics of thrombotic microangiopathy following ABO incompatible living donor liver transplantation. Liver Transplantation 13: 1455-1462, No. 10, Oct 2007 - Japan

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Cyclophosphamide/tacrolimus. React. Wkly. 1181, 13 (2007). https://doi.org/10.2165/00128415-200711810-00037

    Download citation

    Keywords

    • Cyclophosphamide
    • Tacrolimus
    • Immunosuppressive Regimen
    • Epoprostenol
    • Thrombotic Microangiopathy